These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12671184)

  • 21. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet.
    Koohestani N; Tran TT; Lee W; Wolever TM; Bruce WR
    Nutr Cancer; 1997; 29(1):69-76. PubMed ID: 9383787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity-related colon cancer: dietary factors and their mechanisms of anticancer action.
    Zeng H; Lazarova DL
    Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):161-7. PubMed ID: 21418088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colon carcinogenesis: influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compounds.
    Kasdagly M; Radhakrishnan S; Reddivari L; Veeramachaneni DN; Vanamala J
    Nutrition; 2014; 30(11-12):1242-56. PubMed ID: 25280404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of colon cancer cell growth by dietary components: role of the insulin-like growth factor (IGF) system.
    Park JH
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():257-60. PubMed ID: 18296350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic insulin exposure does not cause insulin resistance but is associated with chemo-resistance in colon cancer cells.
    Baricevic I; Roberts DL; Renehan AG
    Horm Metab Res; 2014 Feb; 46(2):85-93. PubMed ID: 24068609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
    Kim YI
    Nutr Rev; 1998 Sep; 56(9):275-9. PubMed ID: 9763878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal programming of colon cancer in adult rats: correlations with altered neonatal growth trajectory, circulating IGF-I and IGF binding proteins, and testosterone.
    Xiao R; Hennings LJ; Badger TM; Simmen FA
    J Endocrinol; 2007 Oct; 195(1):79-87. PubMed ID: 17911399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
    Liu B; Xu T; Xu X; Cui Y; Xing X
    Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes and cancer: what is the connection?
    Cannata D; Fierz Y; Vijayakumar A; LeRoith D
    Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.
    Cowey SL; Quast M; Belalcazar LM; Wei J; Deng X; Given R; Singh P
    Cancer; 2005 Jun; 103(12):2643-53. PubMed ID: 15864814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon.
    Freier S; Weiss O; Eran M; Flyvbjerg A; Dahan R; Nephesh I; Safra T; Shiloni E; Raz I
    Gut; 1999 May; 44(5):704-8. PubMed ID: 10205209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the IGF system in cancer: from basic to clinical studies and clinical applications.
    Moschos SJ; Mantzoros CS
    Oncology; 2002; 63(4):317-32. PubMed ID: 12417786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.
    Chang CK; Ulrich CM
    Diabetologia; 2003 May; 46(5):595-607. PubMed ID: 12764580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer.
    Murtaugh MA; Ma KN; Caan BJ; Sweeney C; Wolff R; Samowitz WS; Potter JD; Slattery ML
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1224-9. PubMed ID: 15894676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity-induced metabolic stresses in breast and colon cancer.
    Sung MK; Yeon JY; Park SY; Park JH; Choi MS
    Ann N Y Acad Sci; 2011 Jul; 1229():61-8. PubMed ID: 21793840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.